Molecular Markers in Peripheral Blood of Patient with Acute Myocardial Infarction
DOI:
https://doi.org/10.3823/2032Keywords:
cyclooxygenase, acute myocardial infarction, atherosclerosis.Abstract
AIms: Cyclooxygenases (COX) are involved in inflammation and in prostaglandin metabolism. It is estimated that the use of blockers causes a steep rise in cardiovascular events when compared with patients who did not use them. The aim of this report is to show the association of the increase in COX-2 expression in relation to time in a patient with acute myocardial infarction (AMI). Methods:A 54-year-old black woman, hypertensive and ex-cocaine user, presented with typical precordial pain and ischemia in the anterior wall of the myocardium identified by an ECG. Serial blood collections were performed in order to evaluate COX-2 and NF-kB gene expressions. Forty days prior the event she had been submitted to percutaneous coronary angioplasty due to AMI. The coronarIography revealed stent thrombosis.Results: COX-2 and NF-kB expressions peaked in the first 24 hours after the thrombotic event. Discussion: There is an increase in COX-2 expression on atherosclerotic plaques. The use of COX-2 blockers increase the risk of ischemia given their vasoconstrictor effect, resulting in a decrease in oxygen supply to the myocardium. In sum, the increase in COX-2 expression was associated with acute coronary event in this patient.
References
- Shinmura K, Tang XL, Wang Y, Xuan YT, LIU SQ, Takano H, et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase os ischemic preconditioning conscious rabbits. Proc Natl Acad Sci USA. 2000; 97: 10197-202
- Bresalier RS, Sandler RS, Quan H, Bolognese JA, Laine L. MEDAL Steering Committee. Clinical trial desing and pacientes demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-Term (MEDAL) study progam: cardiovascular outcomes with etoricoxib versus diclofenac in patientes with osteoarthritis and rheumatoid arthritis. Am Heart J. 2006; 152:237-45.
- Vogel U, Segel S, Dethlefsen C, Tjonneland A, Saber AT, Wallin H, et al. Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. Artherosclerosis 209. 2020; 155:162.
- Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002 Jan;53(1):31-47.
- Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015 May;12(3):305-12. doi: 10.11909/j.issn.1671-5411.2015.03.020.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
Â
Â
